Jim Cramer's Iran-proof portfolio - BloggingStocks: "On last night's MAD MONEY on CNBC, Jim Cramer discussed the ramifications of Iran if things get worse. He laid out a "what to do" plan if you wake up one morning and the headlines are horrible. He has a four point strategy for an "Iran Gone Awry" scenario: First, a drug company, because drug companies don't need a strong economy. Cramer likes Abbott Laboratories (NYSE: ABT), which is even more immune to other drug company problems because it is at its highs. (He doesn't like Pfizer Inc. (NYSE: PFE), Merck & Co. (NYSE: MRK) or Bristol-Myers Squibb (NYSE: BMY)). The 16x P/E and the 14% growth rate make ABT cheap and it sold off two units. He likes its Humira drug as a multi-purpose drug and its stent looks like it may be the best out there.Second, a company tied to oil, but one that won't get hurt if we get cut off from Middle East oil. Cramer chose Kinder Morgan Energy Partners (NYSE: KMP) but he warns not to buy the wrong Kinder Morgan. This one is a safer high-yield one, he says as it transports via its pipelines and transfers other commodities besides oil and gas."